Before administering a client's prescribed nonselective adrenergic blocker, what should the nurse assess?
WBC count
Pulse and blood pressure
Bowel sounds
Serum sodium and potassium levels
The Correct Answer is B
A. Assessing the WBC count is not directly related to the administration of a nonselective adrenergic blocker. These medications primarily affect the cardiovascular system.
B. Assessing pulse and blood pressure is crucial before administering a nonselective adrenergic blocker. These medications can cause bradycardia and hypotension as side effects, so it's
important to ensure the client's baseline pulse and blood pressure are within acceptable ranges before giving the medication.
C. Assessing bowel sounds is not directly related to the administration of a nonselective adrenergic blocker. These medications primarily affect the cardiovascular system.
D. Assessing serum sodium and potassium levels is not directly related to the administration of a nonselective adrenergic blocker. These medications primarily affect the cardiovascular system.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. A lithium level of 0.9 mEq/L falls within the therapeutic range for lithium, so it is not too low.
B. A lithium level of 0.9 mEq/L is within the therapeutic range for lithium maintenance therapy, which typically ranges from 0.6 to 1.2 mEq/L. Therefore, it is considered therapeutic.
C. Lithium is commonly monitored with blood levels to ensure therapeutic efficacy and to prevent toxicity.
D. A lithium level of 0.9 mEq/L is not too high; it is within the therapeutic range.
Correct Answer is A
Explanation
A. Decreased weight: Orlistat is a medication used for weight management by inhibiting the absorption of dietary fats. Its intended therapeutic effect is to promote weight loss by reducing the amount of fat absorbed from the diet.
B. Increased appetite: Orlistat does not increase appetite; rather, it may help control appetite by promoting satiety through its mechanism of action.
C. Decreased hyperactivity: Orlistat is not indicated for the treatment of hyperactivity.
D. Increased wakefulness: Orlistat does not affect wakefulness; it primarily acts in the gastrointestinal tract to inhibit fat absorption.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.